MP:0001262 | decreased body weight | "lower than normal average weight " [J:61295] |
Show
Allelic Composition: Slc17a7tm1Lex/Slc17a7+ Genetic Background: involves: 129S5/SvEvBrd * C57BL/6J
|
MP:0002418 | increased susceptibility to viral infection | "greater likelihood that an organism will develop ill effects from a viral infection or from components of or toxins produced by a virus" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Slc17a7tm1Lex/Slc17a7+ Genetic Background: involves: 129S5/SvEvBrd * C57BL/6J
|
MP:0002451 | abnormal macrophage physiology | "abnormal function or response of the phagocytic leukocytes involved in innate immunity, early non-adaptive phases of host-defense, antigen presentation, and which act as effector cells in humoral and cell-mediated immunity" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Slc17a7tm1Lex/Slc17a7+ Genetic Background: involves: 129S5/SvEvBrd * C57BL/6J
|
MP:0002463 | abnormal neutrophil physiology | "abnormal function of these granular leukocytes, which stain with neutral dyes" [MeSH:National Library of Medicine - Medical Subject Headings , 2003, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Slc17a7tm1Lex/Slc17a7+ Genetic Background: involves: 129S5/SvEvBrd * C57BL/6J
|
MP:0008564 | increased interferon-beta secretion | "increase in the production or release of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Slc17a7tm1Lex/Slc17a7+ Genetic Background: involves: 129S5/SvEvBrd * C57BL/6J
|
MP:0008596 | increased circulating interleukin-6 level | "increase in the amount in the blood of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Slc17a7tm1Lex/Slc17a7+ Genetic Background: involves: 129S5/SvEvBrd * C57BL/6J
|
MP:0008657 | increased interleukin-1 beta secretion | "increase in the production or release of an interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein on monocytes, macrophages and other cells; proteolytic processing of the precursor form by caspase 1 results in release of the active form of interleukin-1beta from the membrane" [MESH:D12.644.276.374.465.501.600] |
Show
Allelic Composition: Slc17a7tm1Lex/Slc17a7+ Genetic Background: involves: 129S5/SvEvBrd * C57BL/6J
|
MP:0008705 | increased interleukin-6 secretion | "increase in the production or release of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Slc17a7tm1Lex/Slc17a7+ Genetic Background: involves: 129S5/SvEvBrd * C57BL/6J
|
MP:0008735 | increased susceptibility to endotoxin shock | "more than the expected early reaction of the microcirculation to endotoxins such as LPS, characterized by movement of fluid and leukocytes from the blood into extravascular tissues and often resulting in death" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Slc17a7tm1Lex/Slc17a7+ Genetic Background: involves: 129S5/SvEvBrd * C57BL/6J
|